Egorov Vv

812 total citations
65 papers, 570 citations indexed

About

Egorov Vv is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Egorov Vv has authored 65 papers receiving a total of 570 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 20 papers in Epidemiology and 8 papers in Immunology. Recurrent topics in Egorov Vv's work include Influenza Virus Research Studies (13 papers), RNA and protein synthesis mechanisms (9 papers) and Hepatitis B Virus Studies (6 papers). Egorov Vv is often cited by papers focused on Influenza Virus Research Studies (13 papers), RNA and protein synthesis mechanisms (9 papers) and Hepatitis B Virus Studies (6 papers). Egorov Vv collaborates with scholars based in Russia, Czechia and Belarus. Egorov Vv's co-authors include Andrey V. Vasin, О. И. Киселев, С. А. Клотченко, Marina A. Plotnikova, Yana Zabrodskaya, Д. В. Лебедев, V. P. Ulin, A. V. Bobyl, Е. И. Теруков and А. В. Швецов and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Journal of Immunological Methods.

In The Last Decade

Egorov Vv

59 papers receiving 555 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Egorov Vv Russia 13 252 188 80 72 69 65 570
Yating Wang China 12 327 1.3× 41 0.2× 48 0.6× 43 0.6× 48 0.7× 31 498
Qihui Liu China 16 207 0.8× 185 1.0× 102 1.3× 237 3.3× 145 2.1× 56 919
Ashlesha Deshpande United States 15 266 1.1× 102 0.5× 200 2.5× 158 2.2× 32 0.5× 33 725
Kentaro Uemura Japan 15 151 0.6× 107 0.6× 41 0.5× 261 3.6× 24 0.3× 37 678
Carmen M. Foster United States 11 356 1.4× 59 0.3× 55 0.7× 54 0.8× 72 1.0× 16 612
Jennifer C. Boer Australia 13 239 0.9× 41 0.2× 176 2.2× 160 2.2× 49 0.7× 35 800
M.J. Miller United States 10 411 1.6× 76 0.4× 189 2.4× 26 0.4× 119 1.7× 16 1.0k
Sorah Yoon United States 18 461 1.8× 60 0.3× 89 1.1× 70 1.0× 85 1.2× 31 993
Zhennan Zhao China 17 230 0.9× 79 0.4× 59 0.7× 121 1.7× 148 2.1× 32 835
Mark A. Skidmore United Kingdom 21 513 2.0× 95 0.5× 81 1.0× 166 2.3× 17 0.2× 47 1.0k

Countries citing papers authored by Egorov Vv

Since Specialization
Citations

This map shows the geographic impact of Egorov Vv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Egorov Vv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Egorov Vv more than expected).

Fields of papers citing papers by Egorov Vv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Egorov Vv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Egorov Vv. The network helps show where Egorov Vv may publish in the future.

Co-authorship network of co-authors of Egorov Vv

This figure shows the co-authorship network connecting the top 25 collaborators of Egorov Vv. A scholar is included among the top collaborators of Egorov Vv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Egorov Vv. Egorov Vv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vv, Egorov, et al.. (2025). Mangiferin as a potential inhibitor of transthyretin fibrillogenesis. Journal of Molecular Graphics and Modelling. 137. 109007–109007.
2.
Zabrodskaya, Yana, Vladimir B. Tsvetkov, Anna-Polina Shurygina, et al.. (2024). How the immune mousetrap works: Structural evidence for the immunomodulatory action of a peptide from influenza NS1 protein. Biophysical Chemistry. 307. 107176–107176. 1 indexed citations
4.
Vv, Egorov, et al.. (2023). Green economy in the paradigm of sustainable development. 1 indexed citations
5.
Vv, Egorov, Yana Zabrodskaya, А. Е. Баранчиков, et al.. (2023). Matrix is everywhere: extracellular DNA is a link between biofilm and mineralization in Bacillus cereus planktonic lifestyle. npj Biofilms and Microbiomes. 9(1). 9–9. 15 indexed citations
6.
Rubel, Aleksandr A., et al.. (2022). Peptide from NSP7 is able to form amyloid-like fibrils: Artifact or challenge to drug design?. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1871(2). 140884–140884. 1 indexed citations
7.
Лебедев, Д. В., et al.. (2021). Neutron Scattering Techniques and Complementary Methods for Structural and Functional Studies of Biological Macromolecules and Large Macromolecular Complexes. Crystallography Reports. 66(2). 242–253. 1 indexed citations
8.
Zabrodskaya, Yana, et al.. (2021). Old dog, new tricks: Influenza A virus NS1 and in vitro fibrillogenesis. Biochimie. 190. 50–56. 6 indexed citations
9.
Maria, Hanna J., A. S. Luyt, Anton Popelka, et al.. (2020). Eco-friendly foam biocomposites based on cellulose extracted from date palm leaves and low-density polyethylene. Functional Composites and Structures. 2(4). 45004–45004. 3 indexed citations
10.
Швецов, А. В., Tatiana Shtam, Egorov Vv, et al.. (2019). Abstract P-36: HBc4M2e Virus-Like Particles for Influenza A Vaccine Development: a Cryo-EM Study. SHILAP Revista de lepidopterología. 9(Suppl_1). S32–S33. 1 indexed citations
11.
Лебедев, Д. В., Yana Zabrodskaya, Vitaliy Pipich, et al.. (2019). Effect of alpha-lactalbumin and lactoferrin oleic acid complexes on chromatin structural organization. Biochemical and Biophysical Research Communications. 520(1). 136–139. 11 indexed citations
12.
Zabrodskaya, Yana, Д. В. Лебедев, А. В. Швецов, et al.. (2018). The amyloidogenicity of the influenza virus PB1-derived peptide sheds light on its antiviral activity. Biophysical Chemistry. 234. 16–23. 12 indexed citations
13.
Timin, Alexander S., Marina A. Plotnikova, Anastasia Semenova, et al.. (2017). COMPARISON OF INFLUENZA A VIRUS INHIBITION IN VITRO BY SIRNA COMPLEXES WITH CHITOSAN DERIVATIVES, POLYETHYLENEIMINE AND HYBRID POLYARGININE-INORGANIC MICROCAPSULES. Problems of Virology. 62(6). 259–265. 6 indexed citations
14.
Vv, Egorov, et al.. (2016). Interaction of the dye Congo red with fibrils of lysozyme, beta2-microglobulin, and transthyretin. Cell and Tissue Biology. 10(6). 468–475. 14 indexed citations
15.
Vasin, Andrey V., Aleksandra V. Petrova, Egorov Vv, et al.. (2016). The influenza A virus NS genome segment displays lineage-specific patterns in predicted RNA secondary structure. BMC Research Notes. 9(1). 279–279. 12 indexed citations
16.
Русинов, В. Л., et al.. (2015). Nucleophilic substitution of nitro group in nitrotriazolotriazines as a model of potential interaction with cysteine-containing proteins. Chemistry of Heterocyclic Compounds. 51(3). 275–280. 18 indexed citations
17.
Vasin, Andrey V., et al.. (2014). Molecular mechanisms enhancing the proteome of influenza A viruses: An overview of recently discovered proteins. Virus Research. 185. 53–63. 137 indexed citations
18.
Vv, Egorov, et al.. (2011). EXPRESSION INE. coliAND PURIFICATION OF THE FIBRILLOGENIC FUSION PROTEINS TTR-sfGFP AND β2M-sfGFP. Preparative Biochemistry & Biotechnology. 41(4). 337–349. 16 indexed citations
19.
Jerebtsova, Marina, С. А. Клотченко, Т. О. Артамонова, et al.. (2010). Mass spectrometry and biochemical analysis of RNA polymerase II: targeting by protein phosphatase-1. Molecular and Cellular Biochemistry. 347(1-2). 79–87. 18 indexed citations
20.
Vv, Egorov, et al.. (2006). Role of the C-terminal fragment of human transthyretin in abnormal fibrillogenesis. Biochemistry (Moscow). 71(5). 543–549. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026